A Clinical Study of FT1 in Patients With Short Bowel Syndrome

NCT07704047 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome
SBS

Interventions

DRUG: FT1
DRUG: Placebo

Sponsor

Chongqing Peg-Bio Biopharm Co., Ltd.